Percutaneous Tibial Nerve Stimulation Beneficial for Overactive Bladder

THURSDAY, June 29, 2023 (HealthDay News) -- For women with overactive bladder (OAB), percutaneous tibial nerve stimulation (PTNS) is associated with improvement of symptoms, according to a study published online May 16 in the Journal of Clinical Medicine.
Connor McPhail, from FBW Gynaecology Plus in Adelaide, Australia, and colleagues conducted a prospective cohort study to examine the long-term efficacy of PTNS treatment for OAB. Women with OAB received PTNS once per week for 12 weeks in phase 1 and then received 12 PTNS treatments over six months in phase 2. A total of 166 women were included in phase 1 and 51 completed phase 2.
The researchers found that compared to baseline, there was a significant reduction in urinary urgency, nocturia, incontinence, and frequency (improvements of 29.8, 29.8, 31.0, and 33.8 percent, respectively). A significant reduction in urinary frequency (improvement of 56.5 percent) was also seen for patients who completed phase 2.
"This study should promote future investigation into the long-term maintenance of the therapeutic benefit of PTNS in the Australian setting, particularly looking at patient demographics to find out who experienced symptomatic improvements, and possibly a comparative study between the benefits and cost of PTNS and surgical treatments, such as intradetrusor injections," the authors write.
Related Posts
Los CDC advierten que muy pocos niños reciben las vacunas recomendadas
JUEVES, 12 de enero de 2023 (HealthDay News) -- Las vacunaciones entre los niños...
AHA News: At 5, She Had Near Total Heart Block. Now, a ‘Generator’ Powers Her Heart.
MONDAY, April 4, 2022 (American Heart Association News) -- Kindergartener Sophia...
Certain Cancers Are on the Rise Among Hispanic Americans
MONDAY, July 3, 2023 (HealthDay News) -- Cancer death rates among Hispanic...
Después de un ataque cardiaco, la rehabilitación cardiaca inicia el camino a la recuperación
VIERNES, 21 de enero de 2022 (HealthDay News) -- Si ha sufrido un ataque...